nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—CYP2C19—epilepsy syndrome	0.268	1	CbGaD
Famotidine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0425	0.101	CbGbCtD
Famotidine—SLC22A8—Valproic Acid—epilepsy syndrome	0.0415	0.0982	CbGbCtD
Famotidine—CYP2C19—Trimethadione—epilepsy syndrome	0.0395	0.0936	CbGbCtD
Famotidine—CYP2C19—Felbamate—epilepsy syndrome	0.0395	0.0936	CbGbCtD
Famotidine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0372	0.088	CbGbCtD
Famotidine—CYP2C19—Clobazam—epilepsy syndrome	0.0322	0.0763	CbGbCtD
Famotidine—CYP2C19—Carbamazepine—epilepsy syndrome	0.0267	0.0633	CbGbCtD
Famotidine—CYP2C19—Primidone—epilepsy syndrome	0.0249	0.059	CbGbCtD
Famotidine—CYP2C19—Phenytoin—epilepsy syndrome	0.024	0.0567	CbGbCtD
Famotidine—CYP2C19—Propofol—epilepsy syndrome	0.0223	0.0529	CbGbCtD
Famotidine—CYP2C19—Phenobarbital—epilepsy syndrome	0.0214	0.0506	CbGbCtD
Famotidine—CYP2C19—Diazepam—epilepsy syndrome	0.0202	0.0479	CbGbCtD
Famotidine—CYP2C19—Zonisamide—epilepsy syndrome	0.0198	0.0468	CbGbCtD
Famotidine—CYP2C19—Valproic Acid—epilepsy syndrome	0.016	0.0378	CbGbCtD
Famotidine—CYP2C19—Topiramate—epilepsy syndrome	0.0144	0.0341	CbGbCtD
Famotidine—Diarrhoea—Felbamate—epilepsy syndrome	7.67e-05	0.000337	CcSEcCtD
Famotidine—Abdominal pain—Lamotrigine—epilepsy syndrome	7.66e-05	0.000337	CcSEcCtD
Famotidine—Body temperature increased—Lamotrigine—epilepsy syndrome	7.66e-05	0.000337	CcSEcCtD
Famotidine—Dysgeusia—Gabapentin—epilepsy syndrome	7.66e-05	0.000337	CcSEcCtD
Famotidine—Dizziness—Diazepam—epilepsy syndrome	7.66e-05	0.000337	CcSEcCtD
Famotidine—Infection—Valproic Acid—epilepsy syndrome	7.65e-05	0.000336	CcSEcCtD
Famotidine—Syncope—Pregabalin—epilepsy syndrome	7.65e-05	0.000336	CcSEcCtD
Famotidine—Leukopenia—Pregabalin—epilepsy syndrome	7.64e-05	0.000336	CcSEcCtD
Famotidine—Rash—Fosphenytoin—epilepsy syndrome	7.61e-05	0.000335	CcSEcCtD
Famotidine—Dermatitis—Fosphenytoin—epilepsy syndrome	7.6e-05	0.000334	CcSEcCtD
Famotidine—Asthenia—Clonazepam—epilepsy syndrome	7.59e-05	0.000334	CcSEcCtD
Famotidine—Back pain—Gabapentin—epilepsy syndrome	7.57e-05	0.000333	CcSEcCtD
Famotidine—Headache—Fosphenytoin—epilepsy syndrome	7.56e-05	0.000332	CcSEcCtD
Famotidine—Hepatitis—Topiramate—epilepsy syndrome	7.56e-05	0.000332	CcSEcCtD
Famotidine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.54e-05	0.000332	CcSEcCtD
Famotidine—Palpitations—Pregabalin—epilepsy syndrome	7.54e-05	0.000331	CcSEcCtD
Famotidine—Asthenia—Phenytoin—epilepsy syndrome	7.54e-05	0.000331	CcSEcCtD
Famotidine—Nausea—Midazolam—epilepsy syndrome	7.52e-05	0.000331	CcSEcCtD
Famotidine—Hallucination—Topiramate—epilepsy syndrome	7.52e-05	0.000331	CcSEcCtD
Famotidine—Muscle spasms—Gabapentin—epilepsy syndrome	7.52e-05	0.000331	CcSEcCtD
Famotidine—Diarrhoea—Zonisamide—epilepsy syndrome	7.51e-05	0.00033	CcSEcCtD
Famotidine—Pharyngitis—Topiramate—epilepsy syndrome	7.5e-05	0.00033	CcSEcCtD
Famotidine—Loss of consciousness—Pregabalin—epilepsy syndrome	7.5e-05	0.00033	CcSEcCtD
Famotidine—Asthenia—Oxcarbazepine—epilepsy syndrome	7.5e-05	0.00033	CcSEcCtD
Famotidine—Pruritus—Clonazepam—epilepsy syndrome	7.48e-05	0.000329	CcSEcCtD
Famotidine—Vomiting—Vigabatrin—epilepsy syndrome	7.48e-05	0.000329	CcSEcCtD
Famotidine—Cough—Pregabalin—epilepsy syndrome	7.44e-05	0.000327	CcSEcCtD
Famotidine—Pruritus—Phenytoin—epilepsy syndrome	7.43e-05	0.000327	CcSEcCtD
Famotidine—Nausea—Levetiracetam—epilepsy syndrome	7.43e-05	0.000327	CcSEcCtD
Famotidine—Rash—Vigabatrin—epilepsy syndrome	7.42e-05	0.000326	CcSEcCtD
Famotidine—Dizziness—Felbamate—epilepsy syndrome	7.41e-05	0.000326	CcSEcCtD
Famotidine—Dermatitis—Vigabatrin—epilepsy syndrome	7.41e-05	0.000326	CcSEcCtD
Famotidine—Pruritus—Oxcarbazepine—epilepsy syndrome	7.39e-05	0.000325	CcSEcCtD
Famotidine—Convulsion—Pregabalin—epilepsy syndrome	7.39e-05	0.000325	CcSEcCtD
Famotidine—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.39e-05	0.000325	CcSEcCtD
Famotidine—Headache—Vigabatrin—epilepsy syndrome	7.37e-05	0.000324	CcSEcCtD
Famotidine—Vomiting—Diazepam—epilepsy syndrome	7.36e-05	0.000324	CcSEcCtD
Famotidine—Anorexia—Valproic Acid—epilepsy syndrome	7.34e-05	0.000323	CcSEcCtD
Famotidine—Rash—Diazepam—epilepsy syndrome	7.3e-05	0.000321	CcSEcCtD
Famotidine—Dermatitis—Diazepam—epilepsy syndrome	7.3e-05	0.000321	CcSEcCtD
Famotidine—Myalgia—Pregabalin—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Famotidine—Arthralgia—Pregabalin—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Famotidine—Chest pain—Pregabalin—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Famotidine—Dizziness—Zonisamide—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Famotidine—Headache—Diazepam—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Famotidine—Anxiety—Pregabalin—epilepsy syndrome	7.24e-05	0.000318	CcSEcCtD
Famotidine—Diarrhoea—Clonazepam—epilepsy syndrome	7.24e-05	0.000318	CcSEcCtD
Famotidine—Anaemia—Gabapentin—epilepsy syndrome	7.23e-05	0.000318	CcSEcCtD
Famotidine—Asthenia—Carbamazepine—epilepsy syndrome	7.19e-05	0.000316	CcSEcCtD
Famotidine—Agitation—Gabapentin—epilepsy syndrome	7.19e-05	0.000316	CcSEcCtD
Famotidine—Diarrhoea—Phenytoin—epilepsy syndrome	7.19e-05	0.000316	CcSEcCtD
Famotidine—Nausea—Fosphenytoin—epilepsy syndrome	7.17e-05	0.000315	CcSEcCtD
Famotidine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.15e-05	0.000314	CcSEcCtD
Famotidine—Erythema multiforme—Topiramate—epilepsy syndrome	7.15e-05	0.000314	CcSEcCtD
Famotidine—Angioedema—Gabapentin—epilepsy syndrome	7.15e-05	0.000314	CcSEcCtD
Famotidine—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.14e-05	0.000314	CcSEcCtD
Famotidine—Vomiting—Felbamate—epilepsy syndrome	7.13e-05	0.000313	CcSEcCtD
Famotidine—Dry mouth—Pregabalin—epilepsy syndrome	7.1e-05	0.000312	CcSEcCtD
Famotidine—Pruritus—Carbamazepine—epilepsy syndrome	7.09e-05	0.000312	CcSEcCtD
Famotidine—Rash—Felbamate—epilepsy syndrome	7.07e-05	0.000311	CcSEcCtD
Famotidine—Dermatitis—Felbamate—epilepsy syndrome	7.06e-05	0.00031	CcSEcCtD
Famotidine—Tinnitus—Topiramate—epilepsy syndrome	7.05e-05	0.00031	CcSEcCtD
Famotidine—Headache—Felbamate—epilepsy syndrome	7.02e-05	0.000309	CcSEcCtD
Famotidine—Confusional state—Pregabalin—epilepsy syndrome	7.02e-05	0.000309	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.02e-05	0.000308	CcSEcCtD
Famotidine—Flushing—Topiramate—epilepsy syndrome	7.02e-05	0.000308	CcSEcCtD
Famotidine—Syncope—Gabapentin—epilepsy syndrome	7.01e-05	0.000308	CcSEcCtD
Famotidine—Leukopenia—Gabapentin—epilepsy syndrome	7e-05	0.000308	CcSEcCtD
Famotidine—Dizziness—Clonazepam—epilepsy syndrome	6.99e-05	0.000307	CcSEcCtD
Famotidine—Nausea—Vigabatrin—epilepsy syndrome	6.99e-05	0.000307	CcSEcCtD
Famotidine—Vomiting—Zonisamide—epilepsy syndrome	6.98e-05	0.000307	CcSEcCtD
Famotidine—Insomnia—Valproic Acid—epilepsy syndrome	6.96e-05	0.000306	CcSEcCtD
Famotidine—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.96e-05	0.000306	CcSEcCtD
Famotidine—Oedema—Pregabalin—epilepsy syndrome	6.96e-05	0.000306	CcSEcCtD
Famotidine—Asthenia—Lamotrigine—epilepsy syndrome	6.95e-05	0.000306	CcSEcCtD
Famotidine—Dizziness—Phenytoin—epilepsy syndrome	6.95e-05	0.000305	CcSEcCtD
Famotidine—Rash—Zonisamide—epilepsy syndrome	6.92e-05	0.000304	CcSEcCtD
Famotidine—Infection—Pregabalin—epilepsy syndrome	6.92e-05	0.000304	CcSEcCtD
Famotidine—Paraesthesia—Valproic Acid—epilepsy syndrome	6.91e-05	0.000304	CcSEcCtD
Famotidine—Palpitations—Gabapentin—epilepsy syndrome	6.91e-05	0.000304	CcSEcCtD
Famotidine—Dermatitis—Zonisamide—epilepsy syndrome	6.91e-05	0.000304	CcSEcCtD
Famotidine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.91e-05	0.000304	CcSEcCtD
Famotidine—Nausea—Diazepam—epilepsy syndrome	6.88e-05	0.000302	CcSEcCtD
Famotidine—Loss of consciousness—Gabapentin—epilepsy syndrome	6.87e-05	0.000302	CcSEcCtD
Famotidine—Headache—Zonisamide—epilepsy syndrome	6.87e-05	0.000302	CcSEcCtD
Famotidine—Diarrhoea—Carbamazepine—epilepsy syndrome	6.86e-05	0.000302	CcSEcCtD
Famotidine—Pruritus—Lamotrigine—epilepsy syndrome	6.86e-05	0.000301	CcSEcCtD
Famotidine—Shock—Pregabalin—epilepsy syndrome	6.85e-05	0.000301	CcSEcCtD
Famotidine—Somnolence—Valproic Acid—epilepsy syndrome	6.85e-05	0.000301	CcSEcCtD
Famotidine—Cough—Gabapentin—epilepsy syndrome	6.83e-05	0.0003	CcSEcCtD
Famotidine—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.82e-05	0.0003	CcSEcCtD
Famotidine—Dyspepsia—Valproic Acid—epilepsy syndrome	6.78e-05	0.000298	CcSEcCtD
Famotidine—Convulsion—Gabapentin—epilepsy syndrome	6.78e-05	0.000298	CcSEcCtD
Famotidine—Vomiting—Clonazepam—epilepsy syndrome	6.72e-05	0.000296	CcSEcCtD
Famotidine—Decreased appetite—Valproic Acid—epilepsy syndrome	6.69e-05	0.000294	CcSEcCtD
Famotidine—Alopecia—Topiramate—epilepsy syndrome	6.68e-05	0.000294	CcSEcCtD
Famotidine—Vomiting—Phenytoin—epilepsy syndrome	6.68e-05	0.000294	CcSEcCtD
Famotidine—Rash—Clonazepam—epilepsy syndrome	6.67e-05	0.000293	CcSEcCtD
Famotidine—Dermatitis—Clonazepam—epilepsy syndrome	6.66e-05	0.000293	CcSEcCtD
Famotidine—Chest pain—Gabapentin—epilepsy syndrome	6.66e-05	0.000293	CcSEcCtD
Famotidine—Arthralgia—Gabapentin—epilepsy syndrome	6.66e-05	0.000293	CcSEcCtD
Famotidine—Myalgia—Gabapentin—epilepsy syndrome	6.66e-05	0.000293	CcSEcCtD
Famotidine—Nausea—Felbamate—epilepsy syndrome	6.66e-05	0.000293	CcSEcCtD
Famotidine—Vomiting—Oxcarbazepine—epilepsy syndrome	6.64e-05	0.000292	CcSEcCtD
Famotidine—Fatigue—Valproic Acid—epilepsy syndrome	6.64e-05	0.000292	CcSEcCtD
Famotidine—Anxiety—Gabapentin—epilepsy syndrome	6.64e-05	0.000292	CcSEcCtD
Famotidine—Anorexia—Pregabalin—epilepsy syndrome	6.64e-05	0.000292	CcSEcCtD
Famotidine—Dizziness—Carbamazepine—epilepsy syndrome	6.63e-05	0.000292	CcSEcCtD
Famotidine—Diarrhoea—Lamotrigine—epilepsy syndrome	6.63e-05	0.000292	CcSEcCtD
Famotidine—Headache—Clonazepam—epilepsy syndrome	6.62e-05	0.000291	CcSEcCtD
Famotidine—Rash—Phenytoin—epilepsy syndrome	6.62e-05	0.000291	CcSEcCtD
Famotidine—Mental disorder—Topiramate—epilepsy syndrome	6.62e-05	0.000291	CcSEcCtD
Famotidine—Dermatitis—Phenytoin—epilepsy syndrome	6.62e-05	0.000291	CcSEcCtD
Famotidine—Rash—Oxcarbazepine—epilepsy syndrome	6.59e-05	0.00029	CcSEcCtD
Famotidine—Pain—Valproic Acid—epilepsy syndrome	6.59e-05	0.00029	CcSEcCtD
Famotidine—Constipation—Valproic Acid—epilepsy syndrome	6.59e-05	0.00029	CcSEcCtD
Famotidine—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.58e-05	0.000289	CcSEcCtD
Famotidine—Headache—Phenytoin—epilepsy syndrome	6.58e-05	0.000289	CcSEcCtD
Famotidine—Headache—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.000288	CcSEcCtD
Famotidine—Nausea—Zonisamide—epilepsy syndrome	6.52e-05	0.000287	CcSEcCtD
Famotidine—Dry mouth—Gabapentin—epilepsy syndrome	6.51e-05	0.000286	CcSEcCtD
Famotidine—Dysgeusia—Topiramate—epilepsy syndrome	6.44e-05	0.000283	CcSEcCtD
Famotidine—Confusional state—Gabapentin—epilepsy syndrome	6.44e-05	0.000283	CcSEcCtD
Famotidine—Dizziness—Lamotrigine—epilepsy syndrome	6.41e-05	0.000282	CcSEcCtD
Famotidine—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.38e-05	0.000281	CcSEcCtD
Famotidine—Oedema—Gabapentin—epilepsy syndrome	6.38e-05	0.000281	CcSEcCtD
Famotidine—Vomiting—Carbamazepine—epilepsy syndrome	6.38e-05	0.00028	CcSEcCtD
Famotidine—Back pain—Topiramate—epilepsy syndrome	6.37e-05	0.00028	CcSEcCtD
Famotidine—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.35e-05	0.000279	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.34e-05	0.000279	CcSEcCtD
Famotidine—Infection—Gabapentin—epilepsy syndrome	6.34e-05	0.000279	CcSEcCtD
Famotidine—Muscle spasms—Topiramate—epilepsy syndrome	6.33e-05	0.000278	CcSEcCtD
Famotidine—Rash—Carbamazepine—epilepsy syndrome	6.32e-05	0.000278	CcSEcCtD
Famotidine—Dermatitis—Carbamazepine—epilepsy syndrome	6.32e-05	0.000278	CcSEcCtD
Famotidine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.3e-05	0.000277	CcSEcCtD
Famotidine—Insomnia—Pregabalin—epilepsy syndrome	6.3e-05	0.000277	CcSEcCtD
Famotidine—Nausea—Clonazepam—epilepsy syndrome	6.28e-05	0.000276	CcSEcCtD
Famotidine—Headache—Carbamazepine—epilepsy syndrome	6.28e-05	0.000276	CcSEcCtD
Famotidine—Shock—Gabapentin—epilepsy syndrome	6.28e-05	0.000276	CcSEcCtD
Famotidine—Paraesthesia—Pregabalin—epilepsy syndrome	6.25e-05	0.000275	CcSEcCtD
Famotidine—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.25e-05	0.000275	CcSEcCtD
Famotidine—Nausea—Phenytoin—epilepsy syndrome	6.24e-05	0.000274	CcSEcCtD
Famotidine—Nausea—Oxcarbazepine—epilepsy syndrome	6.21e-05	0.000273	CcSEcCtD
Famotidine—Somnolence—Pregabalin—epilepsy syndrome	6.19e-05	0.000272	CcSEcCtD
Famotidine—Vomiting—Lamotrigine—epilepsy syndrome	6.16e-05	0.000271	CcSEcCtD
Famotidine—Urticaria—Valproic Acid—epilepsy syndrome	6.12e-05	0.000269	CcSEcCtD
Famotidine—Rash—Lamotrigine—epilepsy syndrome	6.11e-05	0.000269	CcSEcCtD
Famotidine—Dermatitis—Lamotrigine—epilepsy syndrome	6.1e-05	0.000268	CcSEcCtD
Famotidine—Abdominal pain—Valproic Acid—epilepsy syndrome	6.09e-05	0.000268	CcSEcCtD
Famotidine—Body temperature increased—Valproic Acid—epilepsy syndrome	6.09e-05	0.000268	CcSEcCtD
Famotidine—Anorexia—Gabapentin—epilepsy syndrome	6.08e-05	0.000268	CcSEcCtD
Famotidine—Anaemia—Topiramate—epilepsy syndrome	6.08e-05	0.000267	CcSEcCtD
Famotidine—Headache—Lamotrigine—epilepsy syndrome	6.07e-05	0.000267	CcSEcCtD
Famotidine—Decreased appetite—Pregabalin—epilepsy syndrome	6.05e-05	0.000266	CcSEcCtD
Famotidine—Agitation—Topiramate—epilepsy syndrome	6.05e-05	0.000266	CcSEcCtD
Famotidine—Fatigue—Pregabalin—epilepsy syndrome	6e-05	0.000264	CcSEcCtD
Famotidine—Nausea—Carbamazepine—epilepsy syndrome	5.96e-05	0.000262	CcSEcCtD
Famotidine—Constipation—Pregabalin—epilepsy syndrome	5.95e-05	0.000262	CcSEcCtD
Famotidine—Pain—Pregabalin—epilepsy syndrome	5.95e-05	0.000262	CcSEcCtD
Famotidine—Syncope—Topiramate—epilepsy syndrome	5.9e-05	0.000259	CcSEcCtD
Famotidine—Leukopenia—Topiramate—epilepsy syndrome	5.89e-05	0.000259	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.82e-05	0.000256	CcSEcCtD
Famotidine—Palpitations—Topiramate—epilepsy syndrome	5.82e-05	0.000256	CcSEcCtD
Famotidine—Loss of consciousness—Topiramate—epilepsy syndrome	5.78e-05	0.000254	CcSEcCtD
Famotidine—Insomnia—Gabapentin—epilepsy syndrome	5.77e-05	0.000254	CcSEcCtD
Famotidine—Nausea—Lamotrigine—epilepsy syndrome	5.76e-05	0.000253	CcSEcCtD
Famotidine—Cough—Topiramate—epilepsy syndrome	5.74e-05	0.000252	CcSEcCtD
Famotidine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.74e-05	0.000252	CcSEcCtD
Famotidine—Paraesthesia—Gabapentin—epilepsy syndrome	5.73e-05	0.000252	CcSEcCtD
Famotidine—Convulsion—Topiramate—epilepsy syndrome	5.7e-05	0.000251	CcSEcCtD
Famotidine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.69e-05	0.00025	CcSEcCtD
Famotidine—Somnolence—Gabapentin—epilepsy syndrome	5.68e-05	0.00025	CcSEcCtD
Famotidine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.67e-05	0.000249	CcSEcCtD
Famotidine—Dyspepsia—Gabapentin—epilepsy syndrome	5.62e-05	0.000247	CcSEcCtD
Famotidine—Arthralgia—Topiramate—epilepsy syndrome	5.6e-05	0.000246	CcSEcCtD
Famotidine—Myalgia—Topiramate—epilepsy syndrome	5.6e-05	0.000246	CcSEcCtD
Famotidine—Chest pain—Topiramate—epilepsy syndrome	5.6e-05	0.000246	CcSEcCtD
Famotidine—Anxiety—Topiramate—epilepsy syndrome	5.58e-05	0.000245	CcSEcCtD
Famotidine—Decreased appetite—Gabapentin—epilepsy syndrome	5.55e-05	0.000244	CcSEcCtD
Famotidine—Urticaria—Pregabalin—epilepsy syndrome	5.53e-05	0.000243	CcSEcCtD
Famotidine—Asthenia—Valproic Acid—epilepsy syndrome	5.52e-05	0.000243	CcSEcCtD
Famotidine—Fatigue—Gabapentin—epilepsy syndrome	5.5e-05	0.000242	CcSEcCtD
Famotidine—Body temperature increased—Pregabalin—epilepsy syndrome	5.5e-05	0.000242	CcSEcCtD
Famotidine—Abdominal pain—Pregabalin—epilepsy syndrome	5.5e-05	0.000242	CcSEcCtD
Famotidine—Dry mouth—Topiramate—epilepsy syndrome	5.48e-05	0.000241	CcSEcCtD
Famotidine—Constipation—Gabapentin—epilepsy syndrome	5.46e-05	0.00024	CcSEcCtD
Famotidine—Pain—Gabapentin—epilepsy syndrome	5.46e-05	0.00024	CcSEcCtD
Famotidine—Pruritus—Valproic Acid—epilepsy syndrome	5.45e-05	0.00024	CcSEcCtD
Famotidine—Confusional state—Topiramate—epilepsy syndrome	5.42e-05	0.000238	CcSEcCtD
Famotidine—Oedema—Topiramate—epilepsy syndrome	5.37e-05	0.000236	CcSEcCtD
Famotidine—Infection—Topiramate—epilepsy syndrome	5.34e-05	0.000235	CcSEcCtD
Famotidine—Shock—Topiramate—epilepsy syndrome	5.28e-05	0.000232	CcSEcCtD
Famotidine—Diarrhoea—Valproic Acid—epilepsy syndrome	5.27e-05	0.000232	CcSEcCtD
Famotidine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.26e-05	0.000231	CcSEcCtD
Famotidine—Thrombocytopenia—Topiramate—epilepsy syndrome	5.26e-05	0.000231	CcSEcCtD
Famotidine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.22e-05	0.00023	CcSEcCtD
Famotidine—Hypersensitivity—Pregabalin—epilepsy syndrome	5.13e-05	0.000226	CcSEcCtD
Famotidine—Anorexia—Topiramate—epilepsy syndrome	5.12e-05	0.000225	CcSEcCtD
Famotidine—Dizziness—Valproic Acid—epilepsy syndrome	5.09e-05	0.000224	CcSEcCtD
Famotidine—Urticaria—Gabapentin—epilepsy syndrome	5.07e-05	0.000223	CcSEcCtD
Famotidine—Abdominal pain—Gabapentin—epilepsy syndrome	5.05e-05	0.000222	CcSEcCtD
Famotidine—Body temperature increased—Gabapentin—epilepsy syndrome	5.05e-05	0.000222	CcSEcCtD
Famotidine—Asthenia—Pregabalin—epilepsy syndrome	4.99e-05	0.00022	CcSEcCtD
Famotidine—Pruritus—Pregabalin—epilepsy syndrome	4.93e-05	0.000217	CcSEcCtD
Famotidine—Vomiting—Valproic Acid—epilepsy syndrome	4.9e-05	0.000215	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.89e-05	0.000215	CcSEcCtD
Famotidine—Insomnia—Topiramate—epilepsy syndrome	4.86e-05	0.000214	CcSEcCtD
Famotidine—Rash—Valproic Acid—epilepsy syndrome	4.86e-05	0.000213	CcSEcCtD
Famotidine—Dermatitis—Valproic Acid—epilepsy syndrome	4.85e-05	0.000213	CcSEcCtD
Famotidine—Headache—Valproic Acid—epilepsy syndrome	4.82e-05	0.000212	CcSEcCtD
Famotidine—Paraesthesia—Topiramate—epilepsy syndrome	4.82e-05	0.000212	CcSEcCtD
Famotidine—Somnolence—Topiramate—epilepsy syndrome	4.77e-05	0.00021	CcSEcCtD
Famotidine—Diarrhoea—Pregabalin—epilepsy syndrome	4.76e-05	0.000209	CcSEcCtD
Famotidine—Dyspepsia—Topiramate—epilepsy syndrome	4.73e-05	0.000208	CcSEcCtD
Famotidine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.7e-05	0.000207	CcSEcCtD
Famotidine—Decreased appetite—Topiramate—epilepsy syndrome	4.67e-05	0.000205	CcSEcCtD
Famotidine—Fatigue—Topiramate—epilepsy syndrome	4.63e-05	0.000204	CcSEcCtD
Famotidine—Dizziness—Pregabalin—epilepsy syndrome	4.6e-05	0.000202	CcSEcCtD
Famotidine—Pain—Topiramate—epilepsy syndrome	4.59e-05	0.000202	CcSEcCtD
Famotidine—Constipation—Topiramate—epilepsy syndrome	4.59e-05	0.000202	CcSEcCtD
Famotidine—Asthenia—Gabapentin—epilepsy syndrome	4.58e-05	0.000201	CcSEcCtD
Famotidine—Nausea—Valproic Acid—epilepsy syndrome	4.57e-05	0.000201	CcSEcCtD
Famotidine—Pruritus—Gabapentin—epilepsy syndrome	4.52e-05	0.000199	CcSEcCtD
Famotidine—Vomiting—Pregabalin—epilepsy syndrome	4.43e-05	0.000195	CcSEcCtD
Famotidine—Feeling abnormal—Topiramate—epilepsy syndrome	4.43e-05	0.000195	CcSEcCtD
Famotidine—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.39e-05	0.000193	CcSEcCtD
Famotidine—Rash—Pregabalin—epilepsy syndrome	4.39e-05	0.000193	CcSEcCtD
Famotidine—Dermatitis—Pregabalin—epilepsy syndrome	4.39e-05	0.000193	CcSEcCtD
Famotidine—Diarrhoea—Gabapentin—epilepsy syndrome	4.37e-05	0.000192	CcSEcCtD
Famotidine—Headache—Pregabalin—epilepsy syndrome	4.36e-05	0.000192	CcSEcCtD
Famotidine—Urticaria—Topiramate—epilepsy syndrome	4.27e-05	0.000188	CcSEcCtD
Famotidine—Abdominal pain—Topiramate—epilepsy syndrome	4.25e-05	0.000187	CcSEcCtD
Famotidine—Body temperature increased—Topiramate—epilepsy syndrome	4.25e-05	0.000187	CcSEcCtD
Famotidine—Dizziness—Gabapentin—epilepsy syndrome	4.22e-05	0.000186	CcSEcCtD
Famotidine—Nausea—Pregabalin—epilepsy syndrome	4.14e-05	0.000182	CcSEcCtD
Famotidine—Vomiting—Gabapentin—epilepsy syndrome	4.06e-05	0.000178	CcSEcCtD
Famotidine—Rash—Gabapentin—epilepsy syndrome	4.03e-05	0.000177	CcSEcCtD
Famotidine—Dermatitis—Gabapentin—epilepsy syndrome	4.02e-05	0.000177	CcSEcCtD
Famotidine—Headache—Gabapentin—epilepsy syndrome	4e-05	0.000176	CcSEcCtD
Famotidine—Hypersensitivity—Topiramate—epilepsy syndrome	3.96e-05	0.000174	CcSEcCtD
Famotidine—Asthenia—Topiramate—epilepsy syndrome	3.85e-05	0.000169	CcSEcCtD
Famotidine—Pruritus—Topiramate—epilepsy syndrome	3.8e-05	0.000167	CcSEcCtD
Famotidine—Nausea—Gabapentin—epilepsy syndrome	3.79e-05	0.000167	CcSEcCtD
Famotidine—Diarrhoea—Topiramate—epilepsy syndrome	3.67e-05	0.000162	CcSEcCtD
Famotidine—Dizziness—Topiramate—epilepsy syndrome	3.55e-05	0.000156	CcSEcCtD
Famotidine—HRH2—GPCR downstream signaling—SST—epilepsy syndrome	3.47e-05	0.000424	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCR2—epilepsy syndrome	3.47e-05	0.000424	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.47e-05	0.000423	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.45e-05	0.000421	CbGpPWpGaD
Famotidine—Vomiting—Topiramate—epilepsy syndrome	3.41e-05	0.00015	CcSEcCtD
Famotidine—HRH2—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.4e-05	0.000415	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR8—epilepsy syndrome	3.4e-05	0.000415	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NPY2R—epilepsy syndrome	3.4e-05	0.000415	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SSTR1—epilepsy syndrome	3.4e-05	0.000415	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR9—epilepsy syndrome	3.4e-05	0.000415	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.4e-05	0.000415	CbGpPWpGaD
Famotidine—Rash—Topiramate—epilepsy syndrome	3.39e-05	0.000149	CcSEcCtD
Famotidine—Dermatitis—Topiramate—epilepsy syndrome	3.38e-05	0.000149	CcSEcCtD
Famotidine—Headache—Topiramate—epilepsy syndrome	3.36e-05	0.000148	CcSEcCtD
Famotidine—HRH2—Signaling Pathways—GRM4—epilepsy syndrome	3.33e-05	0.000407	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM3—epilepsy syndrome	3.33e-05	0.000407	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.33e-05	0.000406	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLCO1A2—epilepsy syndrome	3.31e-05	0.000404	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNA2D2—epilepsy syndrome	3.31e-05	0.000404	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PFKL—epilepsy syndrome	3.31e-05	0.000404	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—KCNB1—epilepsy syndrome	3.31e-05	0.000404	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC6A8—epilepsy syndrome	3.31e-05	0.000404	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DUSP4—epilepsy syndrome	3.27e-05	0.000399	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SSTR2—epilepsy syndrome	3.27e-05	0.000399	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.26e-05	0.000398	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.26e-05	0.000398	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA13—epilepsy syndrome	3.23e-05	0.000394	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CNR1—epilepsy syndrome	3.2e-05	0.000391	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.19e-05	0.00039	CbGpPWpGaD
Famotidine—Nausea—Topiramate—epilepsy syndrome	3.19e-05	0.00014	CcSEcCtD
Famotidine—HRH2—Signaling Pathways—GRM8—epilepsy syndrome	3.16e-05	0.000386	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PGF—epilepsy syndrome	3.16e-05	0.000386	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.16e-05	0.000385	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—SST—epilepsy syndrome	3.15e-05	0.000385	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR2—epilepsy syndrome	3.15e-05	0.000385	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR7—epilepsy syndrome	3.13e-05	0.000381	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—POMC—epilepsy syndrome	3.09e-05	0.000378	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.09e-05	0.000376	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.08e-05	0.000376	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NEU1—epilepsy syndrome	3.03e-05	0.00037	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ATIC—epilepsy syndrome	3.03e-05	0.00037	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UPB1—epilepsy syndrome	3.03e-05	0.00037	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCL2—epilepsy syndrome	3.03e-05	0.000369	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNAO1—epilepsy syndrome	3.02e-05	0.000368	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OPRD1—epilepsy syndrome	3.02e-05	0.000368	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT3—epilepsy syndrome	2.98e-05	0.000363	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL12—epilepsy syndrome	2.96e-05	0.000362	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.96e-05	0.000362	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.95e-05	0.00036	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.93e-05	0.000357	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSD17B4—epilepsy syndrome	2.92e-05	0.000356	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CNR1—epilepsy syndrome	2.91e-05	0.000355	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PLCB1—epilepsy syndrome	2.9e-05	0.000354	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM1—epilepsy syndrome	2.89e-05	0.000353	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR7—epilepsy syndrome	2.89e-05	0.000353	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDYN—epilepsy syndrome	2.89e-05	0.000353	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CHRM1—epilepsy syndrome	2.89e-05	0.000353	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR7—epilepsy syndrome	2.84e-05	0.000346	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.83e-05	0.000346	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPP1R3C—epilepsy syndrome	2.82e-05	0.000344	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GBE1—epilepsy syndrome	2.82e-05	0.000344	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—PRKCB—epilepsy syndrome	2.76e-05	0.000337	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HBEGF—epilepsy syndrome	2.76e-05	0.000336	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CDC42—epilepsy syndrome	2.72e-05	0.000332	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GAL—epilepsy syndrome	2.72e-05	0.000332	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GFAP—epilepsy syndrome	2.72e-05	0.000332	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT3—epilepsy syndrome	2.71e-05	0.00033	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM5—epilepsy syndrome	2.69e-05	0.000328	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CHRM3—epilepsy syndrome	2.69e-05	0.000328	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP2—epilepsy syndrome	2.69e-05	0.000328	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ASAH1—epilepsy syndrome	2.65e-05	0.000323	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AVP—epilepsy syndrome	2.63e-05	0.000321	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.62e-05	0.000319	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.6e-05	0.000317	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CX3CR1—epilepsy syndrome	2.58e-05	0.000314	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—STXBP1—epilepsy syndrome	2.58e-05	0.000314	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BDKRB1—epilepsy syndrome	2.53e-05	0.000308	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CX3CL1—epilepsy syndrome	2.53e-05	0.000308	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CHRM2—epilepsy syndrome	2.53e-05	0.000308	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NT5E—epilepsy syndrome	2.51e-05	0.000306	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALAD—epilepsy syndrome	2.51e-05	0.000306	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.5e-05	0.000305	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CDC42—epilepsy syndrome	2.47e-05	0.000301	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GABBR1—epilepsy syndrome	2.46e-05	0.0003	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	2.45e-05	0.000298	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CERS1—epilepsy syndrome	2.45e-05	0.000298	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADK—epilepsy syndrome	2.45e-05	0.000298	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PDXK—epilepsy syndrome	2.45e-05	0.000298	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FAR1—epilepsy syndrome	2.45e-05	0.000298	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	2.45e-05	0.000298	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.43e-05	0.000296	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDH7A1—epilepsy syndrome	2.4e-05	0.000292	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNA1A—epilepsy syndrome	2.4e-05	0.000292	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AVP—epilepsy syndrome	2.39e-05	0.000292	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRH3—epilepsy syndrome	2.36e-05	0.000287	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ST3GAL3—epilepsy syndrome	2.34e-05	0.000286	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OPRM1—epilepsy syndrome	2.32e-05	0.000283	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADSL—epilepsy syndrome	2.3e-05	0.00028	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GLUL—epilepsy syndrome	2.25e-05	0.000275	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PNPO—epilepsy syndrome	2.24e-05	0.000273	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GAMT—epilepsy syndrome	2.24e-05	0.000273	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	2.24e-05	0.000273	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	2.24e-05	0.000273	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCR5—epilepsy syndrome	2.24e-05	0.000273	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNA1D—epilepsy syndrome	2.21e-05	0.00027	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR3—epilepsy syndrome	2.19e-05	0.000267	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.19e-05	0.000267	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NPY—epilepsy syndrome	2.14e-05	0.00026	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ATP2A2—epilepsy syndrome	2.14e-05	0.00026	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA4—epilepsy syndrome	2.08e-05	0.000254	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—QDPR—epilepsy syndrome	2.08e-05	0.000254	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGT—epilepsy syndrome	2.08e-05	0.000253	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	2.07e-05	0.000253	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TXNRD1—epilepsy syndrome	2.07e-05	0.000252	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HSPB1—epilepsy syndrome	2.06e-05	0.000251	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL3—epilepsy syndrome	2.06e-05	0.000251	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OXT—epilepsy syndrome	2.06e-05	0.000251	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CRH—epilepsy syndrome	2.06e-05	0.000251	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL2—epilepsy syndrome	2.06e-05	0.000251	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.05e-05	0.000251	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.04e-05	0.000248	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR5—epilepsy syndrome	2.03e-05	0.000248	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AQP1—epilepsy syndrome	2.01e-05	0.000245	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.99e-05	0.000243	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.97e-05	0.000241	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.96e-05	0.000239	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.92e-05	0.000234	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TSC1—epilepsy syndrome	1.92e-05	0.000234	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTK2B—epilepsy syndrome	1.92e-05	0.000234	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGT—epilepsy syndrome	1.89e-05	0.00023	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK2—epilepsy syndrome	1.86e-05	0.000227	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SST—epilepsy syndrome	1.86e-05	0.000227	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR2—epilepsy syndrome	1.86e-05	0.000227	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.85e-05	0.000226	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.85e-05	0.000226	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.85e-05	0.000226	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.85e-05	0.000226	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.85e-05	0.000226	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DUSP6—epilepsy syndrome	1.85e-05	0.000225	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.82e-05	0.000222	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLAT—epilepsy syndrome	1.82e-05	0.000221	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	1.82e-05	0.000221	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—KCNJ11—epilepsy syndrome	1.82e-05	0.000221	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.8e-05	0.00022	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.77e-05	0.000216	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL12—epilepsy syndrome	1.75e-05	0.000214	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.75e-05	0.000214	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—POMC—epilepsy syndrome	1.75e-05	0.000213	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.74e-05	0.000213	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.74e-05	0.000212	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUNB—epilepsy syndrome	1.72e-05	0.00021	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CNR1—epilepsy syndrome	1.72e-05	0.00021	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLCB1—epilepsy syndrome	1.71e-05	0.000209	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.7e-05	0.000207	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.7e-05	0.000207	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.7e-05	0.000207	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR7—epilepsy syndrome	1.68e-05	0.000205	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.63e-05	0.000199	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HBEGF—epilepsy syndrome	1.63e-05	0.000199	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT3—epilepsy syndrome	1.6e-05	0.000195	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—POMC—epilepsy syndrome	1.59e-05	0.000194	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.58e-05	0.000192	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.58e-05	0.000192	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADAM10—epilepsy syndrome	1.56e-05	0.00019	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL2—epilepsy syndrome	1.55e-05	0.00019	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.54e-05	0.000188	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	1.48e-05	0.000181	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	1.48e-05	0.000181	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—S100B—epilepsy syndrome	1.48e-05	0.00018	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SOCS3—epilepsy syndrome	1.46e-05	0.000178	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDC42—epilepsy syndrome	1.46e-05	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	1.44e-05	0.000176	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	1.44e-05	0.000176	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	1.43e-05	0.000175	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AVP—epilepsy syndrome	1.41e-05	0.000172	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NT5E—epilepsy syndrome	1.41e-05	0.000171	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALAD—epilepsy syndrome	1.41e-05	0.000171	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	1.34e-05	0.000164	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	1.34e-05	0.000164	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HES1—epilepsy syndrome	1.34e-05	0.000163	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FYN—epilepsy syndrome	1.3e-05	0.000158	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—H2AFX—epilepsy syndrome	1.29e-05	0.000158	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	1.29e-05	0.000158	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MEF2C—epilepsy syndrome	1.29e-05	0.000158	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADSL—epilepsy syndrome	1.29e-05	0.000157	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GLUL—epilepsy syndrome	1.26e-05	0.000154	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.25e-05	0.000152	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	1.24e-05	0.000151	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGF—epilepsy syndrome	1.23e-05	0.000151	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.23e-05	0.00015	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	1.23e-05	0.00015	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BCHE—epilepsy syndrome	1.23e-05	0.00015	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR5—epilepsy syndrome	1.2e-05	0.000146	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—epilepsy syndrome	1.17e-05	0.000143	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	1.17e-05	0.000143	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	1.16e-05	0.000141	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	1.16e-05	0.000141	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TH—epilepsy syndrome	1.15e-05	0.000141	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AQP1—epilepsy syndrome	1.12e-05	0.000137	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TSC2—epilepsy syndrome	1.12e-05	0.000136	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGT—epilepsy syndrome	1.11e-05	0.000136	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—epilepsy syndrome	1.09e-05	0.000133	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.08e-05	0.000132	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KDR—epilepsy syndrome	1.07e-05	0.000131	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCB—epilepsy syndrome	1.03e-05	0.000126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6ST—epilepsy syndrome	1.03e-05	0.000125	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.02e-05	0.000124	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.02e-05	0.000124	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	9.62e-06	0.000117	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAT—epilepsy syndrome	9.49e-06	0.000116	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.46e-06	0.000115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—POMC—epilepsy syndrome	9.38e-06	0.000114	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.27e-06	0.000113	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	9.24e-06	0.000113	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL2—epilepsy syndrome	9.18e-06	0.000112	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—epilepsy syndrome	8.59e-06	0.000105	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF2—epilepsy syndrome	8.3e-06	0.000101	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	8.28e-06	0.000101	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	8.02e-06	9.79e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.96e-06	9.72e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RELA—epilepsy syndrome	7.7e-06	9.39e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MTOR—epilepsy syndrome	7.55e-06	9.21e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AGT—epilepsy syndrome	7.53e-06	9.18e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—epilepsy syndrome	7.38e-06	9e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.26e-06	8.86e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	7.24e-06	8.83e-05	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—epilepsy syndrome	7.01e-06	8.55e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—epilepsy syndrome	6.95e-06	8.47e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	6.89e-06	8.41e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	6.86e-06	8.37e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUN—epilepsy syndrome	6.75e-06	8.23e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—epilepsy syndrome	6.56e-06	8.01e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	6.55e-06	7.99e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	6.48e-06	7.9e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TH—epilepsy syndrome	6.45e-06	7.87e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—epilepsy syndrome	6.37e-06	7.77e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.35e-06	7.75e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—POMC—epilepsy syndrome	6.34e-06	7.73e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SRC—epilepsy syndrome	6.05e-06	7.38e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—epilepsy syndrome	5.89e-06	7.19e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—epilepsy syndrome	5.78e-06	7.05e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	5.39e-06	6.57e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAT—epilepsy syndrome	5.31e-06	6.48e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	5.17e-06	6.31e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	5.05e-06	6.17e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	4.81e-06	5.86e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AGT—epilepsy syndrome	4.21e-06	5.14e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—epilepsy syndrome	4.13e-06	5.04e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	3.76e-06	4.59e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—POMC—epilepsy syndrome	3.55e-06	4.33e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—epilepsy syndrome	3.23e-06	3.94e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.83e-06	3.45e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	2.54e-06	3.1e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.42e-06	1.73e-05	CbGpPWpGaD
